Physician
Internal Medicine
Dr. Edward D. Frohlich, MD
|
|
Give Review
Edward Frohlich is an expert in the field of Internal Medicine. He researched medicine at University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care He received 4 awards: "CMS Meaningful Use Stage 1 Certification", "Elected Member", "Fellow (FACC)" and "Whos Who in Medicine and Healthcare". Edward Frohlich is also published. He has 85 publications published. The lastest publication: "Clinical Perspectives and Fundamental Aspects of Local Cardiovascular and Renal Renin-Angiotensin Systems.' He is registered with Medicare.
Publications
- Left ventricular hypertrophy: a major factor of risk in black Hypertensive patients.
- Telmisartan prevents excess-salt-induced exacerbated (malignant) hypertension in spontaneously Hypertensive rats.
- Renal denervation using an irrigated radiofrequency ablation catheter for management of drug-resistant hypertension: a demonstrated value?
- Pressure overload.
- Salt consumption and cardiovascular, renal, and hypertensive Diseases: clinical and mechanistic aspects.
- Sodium and its multiorgan targets.
- Predictors of Decline in Medication Adherence: Results From the Cohort Study of Medication Adherence Among Older Adults.
- Epidemiological issues are not simply black and white.
- Novel Concepts in the Genesis of Hypertension: Role of LOX-1.
- On the local cardiac renin angiotensin system. Basic and clinical implications.
- The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.
- Sodium exacerbates ambulatory Heart failure or hypertensive disease.
- Hypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal Models.
- Increased collagen, per se, may not affect left ventricular function in spontaneously Hypertensive rats.
- Quality of life in Hypertensive clinic patients following hurricane katrina.
- Generic drugs: the good, the bad, and the unknown.
- Association of depression with antiHypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO.
- Hypertension and depression: coexisting barriers to medication adherence.
- Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in Hypertensive rats given salt excess.
- Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national Heart, lung, and blood insti...
- A translational approach to hypertensive Heart disease.
- Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension.
- Usefulness of Heart rate as an independent predictor for survival after Heart transplantation.
- Hypertensive Disease: current challenges, new concepts and management. Preface.
- Current challenges and unresolved problems in hypertensive Disease.
- An updated concept for left ventricular hypertrophy risk in hypertension.
- Salt, arterial pressure, and cardioVascular and renal damage.
- Cardiovascular effects of prorenin blockade in genetically spontaneously Hypertensive rats on normal and high-salt diet.
- Excitement of clinical investigation: new basic mechanisms of action after drug introduction.
- Medication adherence in older clinic patients with hypertension after Hurricane Katrina: implications for clinical practice and disaster management.
- Partial adherence to antiHypertensive therapy fails to achieve full cardiovascular benefits in Hypertensive rats.
- Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension.
- AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure.
- Coronary circulation in hypertension and aging: an experimental study.
- Optimal treatment of hypertension with diastolic Heart failure.
- Obesity: a central risk and cardioVascular target of the cardiometabolic syndrome.
- Mentors, role models, and matters of the Heart.
- The salt conundrum: a hypothesis.
- Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously Hypertensive rats.
- Reflections on three decades at ochsner: lecture delivered at the house staff commencement ceremony at the ochsner clinic foundation, june 13, 2007.
- Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR.
- CardioVascular effects of nonproteolytic activation of prorenin.
- Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation.
- Overview for the hypertension issue of Current Opinion in Cardiology.
- Hypertensive renal vascular Disease and cardiovascular endpoints.
- Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system.
- Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR.
- Current challenges in clinical research.
- Hurricane katrina: the challenge to the academic institution.
- The metabolic syndrome: there's little that's new under the sun!
- Hurricane Katrina. Aftershocks.
- Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
- Validation of echocardiographic and Doppler indexes of left ventricular relaxation in adult Hypertensive and normotensive rats.
- Sodium directly impairs target organ function in hypertension.
- Beneficial cardiovascular actions of eplerenone in the spontaneously Hypertensive rat.
- Recent advances in hypertension, stroke, and cardiorenal Disease.
- Physiologic evidence of renoprotection by antiHypertensive therapy.
- Subliminal editorial conundra confounding publication of multicenter trials.
- Seasonal variations in blood pressure.
- Cardiac structural and functional responses to salt loading in SHR.
- Crosslink breakers: a new approach to cardioVascular therapy.
- Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?
- Obesity and suppressed B-type natriuretic peptide levels in Heart failure.
- Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously Hypertensive rats.
- Insulin and insulin resistance: impact on blood pressure and cardiovascular Disease.
- Target organ involvement in hypertension: a realistic promise of prevention and reversal.
- Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age.
- Beneficial pleiotropic vascular effects of rosuvastatin in two Hypertensive models.
- Edward David Frohlich, MD: a conversation with the editor. Interview by William Clifford Roberts.
- Management of diabetic and hypertensive cardiovascular Disease.
- Clinical implications of local renin-angiotensin-aldosterone systems.
- Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamics.
- Robert P. Grant, MD.
- Treating hypertension - what are we to believe?
- Echocardiographic measurement of cardiac output in rats.
- Edward D. Frohlich, MD. A conversation about hypertension: from bedside to bench and return. Interview by Hector O. Ventura.
- Prevention of hypertension.
- High rate of ventricular septal defects in WKY rats.
- Diastolic dysfunction in hypertension.
- Clinical management of the obese Hypertensive patient.
- Annual Progress Report and Our Thanks to Referees.
- Executive Summary: Pivotal Research in CardioVascular Syndromes in the Elderly.
- Hypertension in the Elderly: Lifestyle Modification.
- Clinical Perspectives and Fundamental Aspects of Local CardioVascular and Renal Renin-Angiotensin Systems.
Schools
University Of Maryland School Of Medicine
Washington Dc General Hospital
Georgetown UniversityWashington Dc General Hospital
Procedures Preformed
- Vascular Procedure
Conditions Treated
- Heart Disease
- Hypertensive Heart Disease
- Vascular Disease
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Fellow (FACC)
- Whos Who in Medicine and Healthcare
Education
-
Georgetown University Hospital -
University of Maryland School of Medicine
Hospital
-
Ochsner Medical Center
Drug Facts
| NPI NUMBER | 1467410365 | |
| NPPES Provider LastName | FROHLICH | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 701212429 | |
| NPPES Provider State | LA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 562.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 4.63 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467410365 |
| Last Name Of The Provider | FROHLICH |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
Dr. Omar Khan, DO |